LS
Leonard Sank
Director

Leonard Sank insider trades: Oramed Pharmaceuticals (ORMP) stock purchases

Director, Oramed Pharmaceuticals Last trade Sep 9, 2019 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2008
2
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Leonard reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 9, 2019ORMP↑ Buy$73K
Jul 18, 2019ORMP↑ Buy$196K
Jul 11, 2019ORMP↑ Buy$4K
Oct 4, 2011ORMP.OB↑ Buy$300K
Jan 16, 2008ORMP↑ Buy$5K
Jan 7, 2008ORMP↑ Buy$7K
Jan 3, 2008ORMP↑ Buy$14K
Jan 2, 2008ORMP↑ Buy$59K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ORMP insiders

Open-market trades in the last 12 months

About Leonard Sank's insider trades

Leonard Sank is a director at Oramed Pharmaceuticals (ORMP). Since Jan 2, 2008, Leonard has reported 8 open-market purchases worth $658K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), option exercises (3 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.